The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Automated Cell Imaging System Market Research Report 2025
Synopsis
Automated cellular imaging systems integrate the data generated with other interpretative data and generate actionable insights.Consumables such as cell imaging mediators, washing buffers, and anti-fading agents are used to achieve reliable cell imaging results, ensure cell viability, and maintain physiological temperature, pH, and oxygen tension.It allows users to track individual cell and phenotype changes over time, quantify unlabeled live cell images, and analyze wound healing measurements.
The global Automated Cell Imaging System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Automated Cell Imaging System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Automated Cell Imaging System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Automated Cell Imaging System in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Automated Cell Imaging System include Thermo Fisher Scientific, Molecular Devices, Agilent BioTek, HORIBA, Leica, 3DHISTECH, Cytiva, Oxford Instruments and Fluidigm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Automated Cell Imaging System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Cell Imaging System.
Report Scope
The Automated Cell Imaging System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Cell Imaging System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Cell Imaging System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Molecular Devices
Agilent BioTek
HORIBA
Leica
3DHISTECH
Cytiva
Oxford Instruments
Fluidigm
CytoSMART
Carl Zeiss IMT
PerkinElmer
Hamilton Thorne
SYNENTEC
Olympus Corporation
Sartoriu
Applied Spectral Imaging
Blue-Ray Biotech
Segment by Type
Computer Controlled Type
Touch Screen Operate Type
Segment by Application
Hospital
Diagnostic Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Automated Cell Imaging System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Automated cellular imaging systems integrate the data generated with other interpretative data and generate actionable insights.Consumables such as cell imaging mediators, washing buffers, and anti-fading agents are used to achieve reliable cell imaging results, ensure cell viability, and maintain physiological temperature, pH, and oxygen tension.It allows users to track individual cell and phenotype changes over time, quantify unlabeled live cell images, and analyze wound healing measurements.
The global Automated Cell Imaging System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Automated Cell Imaging System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Automated Cell Imaging System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Automated Cell Imaging System in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Automated Cell Imaging System include Thermo Fisher Scientific, Molecular Devices, Agilent BioTek, HORIBA, Leica, 3DHISTECH, Cytiva, Oxford Instruments and Fluidigm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Automated Cell Imaging System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Cell Imaging System.
Report Scope
The Automated Cell Imaging System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Cell Imaging System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Cell Imaging System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Molecular Devices
Agilent BioTek
HORIBA
Leica
3DHISTECH
Cytiva
Oxford Instruments
Fluidigm
CytoSMART
Carl Zeiss IMT
PerkinElmer
Hamilton Thorne
SYNENTEC
Olympus Corporation
Sartoriu
Applied Spectral Imaging
Blue-Ray Biotech
Segment by Type
Computer Controlled Type
Touch Screen Operate Type
Segment by Application
Hospital
Diagnostic Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Automated Cell Imaging System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Automated Cell Imaging System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Computer Controlled Type
1.2.3 Touch Screen Operate Type
1.3 Market by Application
1.3.1 Global Automated Cell Imaging System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic Laboratory
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Automated Cell Imaging System Market Perspective (2019-2030)
2.2 Automated Cell Imaging System Growth Trends by Region
2.2.1 Global Automated Cell Imaging System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Automated Cell Imaging System Historic Market Size by Region (2019-2024)
2.2.3 Automated Cell Imaging System Forecasted Market Size by Region (2025-2030)
2.3 Automated Cell Imaging System Market Dynamics
2.3.1 Automated Cell Imaging System Industry Trends
2.3.2 Automated Cell Imaging System Market Drivers
2.3.3 Automated Cell Imaging System Market Challenges
2.3.4 Automated Cell Imaging System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Automated Cell Imaging System Players by Revenue
3.1.1 Global Top Automated Cell Imaging System Players by Revenue (2019-2024)
3.1.2 Global Automated Cell Imaging System Revenue Market Share by Players (2019-2024)
3.2 Global Automated Cell Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Automated Cell Imaging System Revenue
3.4 Global Automated Cell Imaging System Market Concentration Ratio
3.4.1 Global Automated Cell Imaging System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Automated Cell Imaging System Revenue in 2023
3.5 Automated Cell Imaging System Key Players Head office and Area Served
3.6 Key Players Automated Cell Imaging System Product Solution and Service
3.7 Date of Enter into Automated Cell Imaging System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Automated Cell Imaging System Breakdown Data by Type
4.1 Global Automated Cell Imaging System Historic Market Size by Type (2019-2024)
4.2 Global Automated Cell Imaging System Forecasted Market Size by Type (2025-2030)
5 Automated Cell Imaging System Breakdown Data by Application
5.1 Global Automated Cell Imaging System Historic Market Size by Application (2019-2024)
5.2 Global Automated Cell Imaging System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Automated Cell Imaging System Market Size (2019-2030)
6.2 North America Automated Cell Imaging System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Automated Cell Imaging System Market Size by Country (2019-2024)
6.4 North America Automated Cell Imaging System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Automated Cell Imaging System Market Size (2019-2030)
7.2 Europe Automated Cell Imaging System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Automated Cell Imaging System Market Size by Country (2019-2024)
7.4 Europe Automated Cell Imaging System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Automated Cell Imaging System Market Size (2019-2030)
8.2 Asia-Pacific Automated Cell Imaging System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Automated Cell Imaging System Market Size by Region (2019-2024)
8.4 Asia-Pacific Automated Cell Imaging System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Automated Cell Imaging System Market Size (2019-2030)
9.2 Latin America Automated Cell Imaging System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Automated Cell Imaging System Market Size by Country (2019-2024)
9.4 Latin America Automated Cell Imaging System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Automated Cell Imaging System Market Size (2019-2030)
10.2 Middle East & Africa Automated Cell Imaging System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Automated Cell Imaging System Market Size by Country (2019-2024)
10.4 Middle East & Africa Automated Cell Imaging System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Automated Cell Imaging System Introduction
11.1.4 Thermo Fisher Scientific Revenue in Automated Cell Imaging System Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Molecular Devices
11.2.1 Molecular Devices Company Detail
11.2.2 Molecular Devices Business Overview
11.2.3 Molecular Devices Automated Cell Imaging System Introduction
11.2.4 Molecular Devices Revenue in Automated Cell Imaging System Business (2019-2024)
11.2.5 Molecular Devices Recent Development
11.3 Agilent BioTek
11.3.1 Agilent BioTek Company Detail
11.3.2 Agilent BioTek Business Overview
11.3.3 Agilent BioTek Automated Cell Imaging System Introduction
11.3.4 Agilent BioTek Revenue in Automated Cell Imaging System Business (2019-2024)
11.3.5 Agilent BioTek Recent Development
11.4 HORIBA
11.4.1 HORIBA Company Detail
11.4.2 HORIBA Business Overview
11.4.3 HORIBA Automated Cell Imaging System Introduction
11.4.4 HORIBA Revenue in Automated Cell Imaging System Business (2019-2024)
11.4.5 HORIBA Recent Development
11.5 Leica
11.5.1 Leica Company Detail
11.5.2 Leica Business Overview
11.5.3 Leica Automated Cell Imaging System Introduction
11.5.4 Leica Revenue in Automated Cell Imaging System Business (2019-2024)
11.5.5 Leica Recent Development
11.6 3DHISTECH
11.6.1 3DHISTECH Company Detail
11.6.2 3DHISTECH Business Overview
11.6.3 3DHISTECH Automated Cell Imaging System Introduction
11.6.4 3DHISTECH Revenue in Automated Cell Imaging System Business (2019-2024)
11.6.5 3DHISTECH Recent Development
11.7 Cytiva
11.7.1 Cytiva Company Detail
11.7.2 Cytiva Business Overview
11.7.3 Cytiva Automated Cell Imaging System Introduction
11.7.4 Cytiva Revenue in Automated Cell Imaging System Business (2019-2024)
11.7.5 Cytiva Recent Development
11.8 Oxford Instruments
11.8.1 Oxford Instruments Company Detail
11.8.2 Oxford Instruments Business Overview
11.8.3 Oxford Instruments Automated Cell Imaging System Introduction
11.8.4 Oxford Instruments Revenue in Automated Cell Imaging System Business (2019-2024)
11.8.5 Oxford Instruments Recent Development
11.9 Fluidigm
11.9.1 Fluidigm Company Detail
11.9.2 Fluidigm Business Overview
11.9.3 Fluidigm Automated Cell Imaging System Introduction
11.9.4 Fluidigm Revenue in Automated Cell Imaging System Business (2019-2024)
11.9.5 Fluidigm Recent Development
11.10 CytoSMART
11.10.1 CytoSMART Company Detail
11.10.2 CytoSMART Business Overview
11.10.3 CytoSMART Automated Cell Imaging System Introduction
11.10.4 CytoSMART Revenue in Automated Cell Imaging System Business (2019-2024)
11.10.5 CytoSMART Recent Development
11.11 Carl Zeiss IMT
11.11.1 Carl Zeiss IMT Company Detail
11.11.2 Carl Zeiss IMT Business Overview
11.11.3 Carl Zeiss IMT Automated Cell Imaging System Introduction
11.11.4 Carl Zeiss IMT Revenue in Automated Cell Imaging System Business (2019-2024)
11.11.5 Carl Zeiss IMT Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Detail
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Automated Cell Imaging System Introduction
11.12.4 PerkinElmer Revenue in Automated Cell Imaging System Business (2019-2024)
11.12.5 PerkinElmer Recent Development
11.13 Hamilton Thorne
11.13.1 Hamilton Thorne Company Detail
11.13.2 Hamilton Thorne Business Overview
11.13.3 Hamilton Thorne Automated Cell Imaging System Introduction
11.13.4 Hamilton Thorne Revenue in Automated Cell Imaging System Business (2019-2024)
11.13.5 Hamilton Thorne Recent Development
11.14 SYNENTEC
11.14.1 SYNENTEC Company Detail
11.14.2 SYNENTEC Business Overview
11.14.3 SYNENTEC Automated Cell Imaging System Introduction
11.14.4 SYNENTEC Revenue in Automated Cell Imaging System Business (2019-2024)
11.14.5 SYNENTEC Recent Development
11.15 Olympus Corporation
11.15.1 Olympus Corporation Company Detail
11.15.2 Olympus Corporation Business Overview
11.15.3 Olympus Corporation Automated Cell Imaging System Introduction
11.15.4 Olympus Corporation Revenue in Automated Cell Imaging System Business (2019-2024)
11.15.5 Olympus Corporation Recent Development
11.16 Sartoriu
11.16.1 Sartoriu Company Detail
11.16.2 Sartoriu Business Overview
11.16.3 Sartoriu Automated Cell Imaging System Introduction
11.16.4 Sartoriu Revenue in Automated Cell Imaging System Business (2019-2024)
11.16.5 Sartoriu Recent Development
11.17 Applied Spectral Imaging
11.17.1 Applied Spectral Imaging Company Detail
11.17.2 Applied Spectral Imaging Business Overview
11.17.3 Applied Spectral Imaging Automated Cell Imaging System Introduction
11.17.4 Applied Spectral Imaging Revenue in Automated Cell Imaging System Business (2019-2024)
11.17.5 Applied Spectral Imaging Recent Development
11.18 Blue-Ray Biotech
11.18.1 Blue-Ray Biotech Company Detail
11.18.2 Blue-Ray Biotech Business Overview
11.18.3 Blue-Ray Biotech Automated Cell Imaging System Introduction
11.18.4 Blue-Ray Biotech Revenue in Automated Cell Imaging System Business (2019-2024)
11.18.5 Blue-Ray Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
